U.S. Markets closed
  • S&P 500

    3,970.99
    +22.27 (+0.56%)
     
  • Dow 30

    32,237.53
    +132.28 (+0.41%)
     
  • Nasdaq

    11,823.96
    +36.56 (+0.31%)
     
  • Russell 2000

    1,734.92
    +14.63 (+0.85%)
     
  • Crude Oil

    69.20
    -0.76 (-1.09%)
     
  • Gold

    1,981.00
    -14.90 (-0.75%)
     
  • Silver

    23.36
    +0.11 (+0.47%)
     
  • EUR/USD

    1.0763
    -0.0073 (-0.6781%)
     
  • 10-Yr Bond

    3.3800
    -0.0260 (-0.76%)
     
  • Vix

    21.74
    -0.87 (-3.85%)
     
  • GBP/USD

    1.2232
    -0.0057 (-0.4624%)
     
  • USD/JPY

    130.6700
    -0.1190 (-0.0910%)
     
  • BTC-USD

    27,542.76
    -50.49 (-0.18%)
     
  • CMC Crypto 200

    597.33
    -21.06 (-3.41%)
     
  • FTSE 100

    7,405.45
    -94.15 (-1.26%)
     
  • Nikkei 225

    27,385.25
    -34.36 (-0.13%)
     

New Strong Sell Stocks for January 24th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

ABM Industries Incorporated ABM engages in the provision of integrated facility, infrastructure, and mobility solutions. The Zacks Consensus Estimate for its current year earnings has been revised 5.9% downward over the last 60 days.

BrainsWay Ltd. BWAY manufactures non-invasive neurostimulation treatments for mental health disorders. The Zacks Consensus Estimate for its current year earnings has been revised 10.8% downward over the last 60 days.

DXP Enterprises, Inc. DXPE engages in distributing maintenance, repair, and operating products, equipment, and services to the energy and industrial customers. The Zacks Consensus Estimate for its current year earnings has been revised 3.4% downward over the last 60 days.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ABM Industries Incorporated (ABM) : Free Stock Analysis Report

DXP Enterprises, Inc. (DXPE) : Free Stock Analysis Report

Brainsway Ltd. Sponsored ADR (BWAY) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research